Some of these reported targets are cancer-related and are associated with carcinogenesis (such as SPRY2, SKY and SRSF3), cancer prognosis (such as CNOT6, RECK and GID4) or cancer cell plasticity (such as RMND5A) [28,29,30,31]. Here, SPRY2 is linked to cancer.